Related Experiment Videos
Phospholipases A2 in ras-transfected fibroblasts
C J Guthridge1, S G Zimmer, M R Steiner
1Department of Microbiology and Immunology, University of Kentucky, Lexington 40536, USA.
Anticancer Research
|September 1, 1995
Summary
Ras oncogene expression increases specific phospholipase A2 (PLA2) activities, particularly cytosolic and group II PLA2, promoting neoplastic progression. These findings highlight PLA2
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phospholipase A2 (PLA2) enzymes generate lipid mediators implicated in cancer progression.
- Ras oncogene activation is a key event in tumorigenesis.
- Understanding PLA2 alterations in oncogene-expressing cells is crucial for cancer research.
Purpose of the Study:
- To investigate specific alterations in PLA2 activities associated with ras oncogene expression.
- To compare PLA2 activities between non-tumorigenic and tumorigenic rat cells.
Main Methods:
- Comparison of PLA2 activities in CREF cells (non-tumorigenic) and CREF-T24 cells (ras-transfected, tumorigenic).
- Western blotting to analyze enzyme levels and phosphorylation status.
- Biochemical assays to characterize PLA2 activities in cellular fractions.
Main Results:
- High molecular mass cytosolic PLA2 activity was 2-3 fold higher in CREF-T24 cells.
- Increased levels and phosphorylation of this cytosolic PLA2 were observed in CREF-T24 cells.
- A group II PLA2 activity was readily detected in CREF-T24 cells but minimal in CREF cells.
- Both cell types showed similar Ca2+-independent, particulate fraction-associated PLA2 activities.
Conclusions:
- Ras oncogene expression leads to significant increases in specific PLA2 activities, including cytosolic and group II PLA2.
- These PLA2 alterations are associated with enhanced release of arachidonic acid, potentially facilitating neoplastic progression.
- PLA2 enzymes represent potential targets for therapeutic intervention in ras-driven cancers.